|Bid||6.11 x 1200|
|Ask||7.60 x 1400|
|Day's range||7.01 - 7.48|
|52-week range||5.31 - 46.91|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||5.21|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Image source: The Motley Fool. Atea Pharmaceuticals, Inc. (NASDAQ: AVIR)Q1 2022 Earnings CallMay 10, 2022, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the Atea Pharmaceuticals first quarter 2022 earnings conference call.
Atea Pharmaceuticals, Inc. (AVIR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Thank you, and good afternoon, everyone, and welcome to Atea Pharmaceuticals' fourth quarter and full year 2021 financial results conference call. With me today from Atea are chief executive officer and founder, Dr.